Tenderwize
Back to tender search

Non-exclusive Discount Agreement for Sevofluran (Open-House)

AOK Niedersachsen. Die Gesundheitskasse.·Hannover, Germany·Deadline Apr 27, 2028 · 613 days left·Open·Supplies·Framework
Structured notice only
Original notice title

Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V für die im Rahmen des Sprechstundenbedarfs in Niedersachsen verordnungs- und abgabefähigen Arzneimittel mit dem Wirkstoff Sevofluran (ATC-Code: N01AB08).

50/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

50 / 100

Complexity

20 / 100

Risk factors

No procurement documents were analyzed; required documents and exact conditions unknown.

No estimated value or volume data provided; financial potential is unclear.

No procurement documents available

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jun 2028
  • Supply of Sevofluran (ATC N01AB08) as finished medicinal products for office supply in Lower Saxony
  • Provision of discount agreements under §130a Abs. 8 SGB V
Show full summary

Non-exclusive discount agreement (open-house model) for the active substance Sevofluran (ATC N01AB08) for office supply needs in Lower Saxony, Germany. The contract runs from 01.07.2026 to 30.06.2028, with rolling enrollment. All interested pharmaceutical entrepreneurs meeting eligibility can join under uniform, non-negotiable conditions. No selection decision is made by the buyer.

Risks

No procurement documents were analyzed; required documents and exact conditions unknown.

No estimated value or volume data provided; financial potential is unclear.

No procurement documents available

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical entrepreneur (pharmazeutischer Unternehmer) as per §4 Abs. 18 AMG
  • Must have establishment in EU/EEA (AMG §9 Abs. 2)
  • Products must be approved for the German market

Requirements may be incomplete.

Award Criteria

Lot 1

No award criteria; no selection process.

Buyer

Location

Hannover, DEU

Identifier

AOK- Niedersachsen. Die Gesundheitskasse

Activity

Health

Lots (1)

LOT-0000

Non-exclusive Discount Agreement for Sevofluran (Open-House)

Open-house model for Sevofluran (ATC N01AB08) for office supply in Lower Saxony. No selection; uniform conditions for all participants. Contracts last up to 24 months, ending 30.06.2028.

SuppliesFrameworkEU fundedElectronic submission

Location

DE929, Germany

Duration

Jun 2026 - Jun 2028

Category

Pharmaceutical products

Award Criteria

No award criteria; no selection process.

Deadline

Deadline Apr 27, 2028

Procurement Details

Publication date
14 May 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
334218-2026

Similar tenders